(Q35076739)

6 August 2017

1 reference

title

Adenosine monophosphate bronchial provocation and the actions of asthma therapy (English)

1 reference

6 August 2017

1 reference

Lee DK

1

1 reference

6 August 2017

Gray RD

series ordinal

2

1 reference

6 August 2017

Lipworth BJ

series ordinal

3

1 reference

6 August 2017

language of work or name

1 reference

1 March 2003

1 reference

Clinical & Experimental Allergy

6 August 2017

published in

1 reference

6 August 2017

volume

33

1 reference

6 August 2017

issue

3

1 reference

6 August 2017

page(s)

287-294

1 reference

Evolving concepts on the value of adenosine hyperresponsiveness in asthma and chronic obstructive pulmonary disease

6 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2745.2003.01620.X

Provocation with adenosine 5'-monophosphate as a marker of inflammation in asthma, allergic rhinitis and chronic obstructive pulmonary disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2745.2003.01620.X

Corticosteroid-induced improvement in the PC20 of adenosine monophosphate is more closely associated with reduction in airway inflammation than improvement in the PC20 of methacholine

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2745.2003.01620.X

Bronchial responsiveness to adenosine 5'-monophosphate (AMP) and methacholine differ in their relationship with airway allergy and baseline FEV(1).

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2745.2003.01620.X

Role of exhaled nitric oxide in asthma

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2745.2003.01620.X

Exhaled NO and assessment of anti-inflammatory effects of inhaled steroid: dose-response relationship

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2745.2003.01620.X

Assessing airway inflammation: from guessing to quantitative measurements.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2745.2003.01620.X

PC(20) adenosine 5'-monophosphate is more closely associated with airway inflammation in asthma than PC(20) methacholine.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2745.2003.01620.X

Long-term effects of budesonide or nedocromil in children with asthma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2745.2003.01620.X

Effects of adding either a leukotriene receptor antagonist or low-dose theophylline to a low or medium dose of inhaled corticosteroid in patients with persistent asthma

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2745.2003.01620.X

Specific antagonism of adenosine-induced bronchoconstriction in asthma by oral theophylline

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2745.2003.01620.X

Adenosine-mediated bronchoconstriction and lung inflammation in an allergic mouse model

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2745.2003.01620.X

Antagonism of long-acting beta2-adrenoceptor agonism

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2745.2003.01620.X

Regular inhaled salbutamol : effect on airway responsiveness to methacholine and adenosine 5'-monophosphate and tolerance to bronchoprotection

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2745.2003.01620.X

Beta-agonist intrinsic efficacy: measurement and clinical significance

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2745.2003.01620.X

A bolus of inhaled budesonide rapidly reverses airway subsensitivity and beta2-adrenoceptor down-regulation after regular inhaled formoterol.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2745.2003.01620.X

Placebo-controlled immunopathologic study of four months of inhaled corticosteroids in asthma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2745.2003.01620.X

A comparison of topical budesonide and oral montelukast in seasonal allergic rhinitis and asthma

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2745.2003.01620.X

Fexofenadine decreases sensitivity to and montelukast improves recovery from inhaled mannitol

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2745.2003.01620.X

The effect of 2 weeks treatment with cetirizine on bronchial reactivity to methacholine in asthma

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2745.2003.01620.X

Role of cysteinyl leukotrienes in adenosine 5'-monophosphate induced bronchoconstriction in asthma

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2745.2003.01620.X

Comparative efficacy and anti-inflammatory profile of once-daily therapy with leukotriene antagonist or low-dose inhaled corticosteroid in patients with mild persistent asthma

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2745.2003.01620.X

Leukotriene-receptor antagonists

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2745.2003.01620.X

Combined antagonism of leukotrienes and histamine produces predominant inhibition of allergen-induced early and late phase airway obstruction in asthmatics

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2745.2003.01620.X

Evaluation of salmeterol or montelukast as second-line therapy for asthma not controlled with inhaled corticosteroids

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2745.2003.01620.X

Effects of adding a leukotriene antagonist or a long-acting beta(2)-agonist in asthmatic patients with the glycine-16 beta(2)-adrenoceptor genotype

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2745.2003.01620.X

Anti-inflammatory effects of zileuton in a subpopulation of allergic asthmatics

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2745.2003.01620.X

Subsensitivity to bronchoprotection against adenosine monophosphate challenge following regular once-daily formoterol

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2745.2003.01620.X

The Role of Histamine in Allergen and Adenosine-Induced Bronchoconstriction

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2745.2003.01620.X

NO in Exhaled Air of Asthmatic Children Is Reduced by the Leukotriene Receptor Antagonist Montelukast

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2745.2003.01620.X

Screening for bronchial hyperresponsiveness using methacholine and adenosine monophosphate. Relationship to asthma severity and beta(2)-receptor genotype

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2745.2003.01620.X

Adolescents in clinical remission of atopic asthma have elevated exhaled nitric oxide levels and bronchial hyperresponsiveness

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2745.2003.01620.X

Comparison of salmeterol and albuterol-induced bronchoprotection against adenosine monophosphate and histamine in mild asthma

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2745.2003.01620.X

Differential Effect of Formoterol on Adenosine Monophosphate and Histamine Reactivity in Asthma

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2745.2003.01620.X

The effects of regular inhaled formoterol, budesonide, and placebo on mucosal inflammation and clinical indices in mild asthma

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2745.2003.01620.X

Systemic corticosteriod rapidly reverses bronchodilator subsensitivity induced by formoterol in asthmatic patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2745.2003.01620.X

Dose-response evaluation of the therapeutic index for inhaled budesonide in patients with mild-to-moderate asthma

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2745.2003.01620.X

Greater effect of inhaled budesonide on adenosine 5'-monophosphate-induced than on sodium-metabisulfite-induced bronchoconstriction in asthma

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2745.2003.01620.X

A dose-dependent effect of the novel inhaled corticosteroid ciclesonide on airway responsiveness to adenosine-5'-monophosphate in asthmatic patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2745.2003.01620.X

Mometasone furoate antagonizes AMP-induced bronchoconstriction in patients with mild asthma

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2745.2003.01620.X

Adenosine inhibits and potentiates IgE-dependent histamine release from human lung mast cells by an A2-purinoceptor mediated mechanism

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2745.2003.01620.X

Adenosine potentiates mediator release from human lung mast cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2745.2003.01620.X

The contribution of histamine to immediate bronchoconstriction provoked by inhaled allergen and adenosine 5' monophosphate in atopic asthma

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2745.2003.01620.X

Additive bronchoprotective and bronchodilator effects with single doses of salmeterol and montelukast in asthmatic patients receiving inhaled corticosteroids

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2745.2003.01620.X

Montelukast, a leukotriene-receptor antagonist, for the treatment of mild asthma and exercise-induced bronchoconstriction

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2745.2003.01620.X

Antiasthmatic effects of mediator blockade versus topical corticosteroids in allergic rhinitis and asthma

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2745.2003.01620.X

Montelukast, a leukotriene receptor antagonist, in combination with loratadine, a histamine receptor antagonist, in the treatment of chronic asthma

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2745.2003.01620.X

Leukotriene antagonist prevents exacerbation of asthma during reduction of high-dose inhaled corticosteroid. The Tokyo Joshi-Idai Asthma Research Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2745.2003.01620.X

Oral montelukast compared with inhaled salmeterol to prevent exercise-induced bronchoconstriction. A randomized, double-blind trial. Exercise Study Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2745.2003.01620.X

10.1046/J.1365-2745.2003.01620.X

21 January 2018

Identifiers

DOI

1 reference

release_qoka3miyajd6rihgwewfv5k5n4

6 August 2017

Fatcat ID

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/qoka3miyajd6rihgwewfv5k5n4

mapped directly with Wikidata item

24 November 2022

based on heuristic

1 reference